1. Home
  2. VVPR vs RLYB Comparison

VVPR vs RLYB Comparison

Compare VVPR & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoPower International PLC

VVPR

VivoPower International PLC

HOLD

Current Price

$2.07

Market Cap

34.8M

Sector

Utilities

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$9.50

Market Cap

28.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVPR
RLYB
Founded
2014
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.8M
28.7M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
VVPR
RLYB
Price
$2.07
$9.50
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
977.4K
251.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.00
52 Week Low
$0.74
$0.22
52 Week High
$8.88
$11.49

Technical Indicators

Market Signals
Indicator
VVPR
RLYB
Relative Strength Index (RSI) 48.19 72.79
Support Level $1.20 $0.48
Resistance Level $2.90 $11.49
Average True Range (ATR) 0.25 0.90
MACD -0.03 -0.25
Stochastic Oscillator 22.64 64.60

Price Performance

Historical Comparison
VVPR
RLYB

About VVPR VivoPower International PLC

Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: